Jazz Pharmaceuticals plc SEC filings JAZZ
Jazz Pharmaceuticals plc has 1,000 filings in SEC EDGAR's recent list, going back to Jun 20, 2017. Its latest annual report, Form ARS, was filed on Jun 8, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 2, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Mar 2, 2022 | — |
| S-8 | Employee stock plan registration | May 7, 2021 | — |
| S-8 | Employee stock plan registration | Feb 23, 2021 | — |
| S-8 POS | Filing | Nov 3, 2020 | — |
| S-8 | Employee stock plan registration | Nov 2, 2020 | — |
| S-8 | Employee stock plan registration | Feb 25, 2020 | — |
| S-8 | Employee stock plan registration | Feb 26, 2019 | — |
| S-8 | Employee stock plan registration | May 9, 2018 | — |
Showing 8 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- JAZZ (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Ireland
- Headquarters
- Dublin
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1232524
- Former names
- JAZZ PHARMACEUTICALS INC (until Jan 18, 2012)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.